Latest Breaking News On - Clara maria scarlata - Page 1 : comparemela.com

/PRNewswire/ Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a late stage, oncology-focused drug development company, is pleased to announce two.

United statesNew south walesMichael esquerreJoel tuyaretMichael fitzgeraldMarie mandron evotecPhilippe cassierMaha ayyoubPhilippe rochaixLise davennePierre benoit anceyClara maria scarlataNathalie delesque touchardMarie mandronCarlos gomez rocaChristophe caux